Literature DB >> 6137857

A new physiological tool for assessing anxiolytic effects in humans: frontal midline theta activity.

Y Mizuki, M Hashimoto, T Tanaka, K Inanaga, M Tanaka.   

Abstract

The theta activity which appears in the frontal midline area during performance of mental tasks has been designated as "Fm theta". In the present study, the possible use of zopiclone as an anxiolytic agent was investigated using Fm theta, in a comparison with diazepam. Sixteen male university students were given placebo, diazepam 5 mg, zopiclone 5 mg and 10 mg, in a double-blind, cross-over design. EEGs were recorded before and during performance of an arithmetic addition test. This test was repeated twice, prior to and 1 h following drug administration. Diazepam markedly increased Fm theta; however, both zopiclone 10 mg and placebo only slightly affected Fm theta, while zopiclone 5 mg failed to affect Fm theta. Scores of state anxiety were reduced markedly by diazepam and only slightly by zopiclone 10 mg, but were not affected by either zopiclone 5 mg or by placebo. Task performance was reduced markedly and in a dose-dependent manner by zopiclone, and very slightly by diazepam. These results suggest that zopiclone possesses a rather potent hypnotic effect, rather than an anxiolytic effect, and that Fm theta might be a useful tool in predicting the clinical efficacy of anxiolytic drugs in normal humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137857     DOI: 10.1007/bf00432111

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  4 in total

1.  Multivariate analytic study of EEG and mental activity in juvenile delinquents.

Authors:  T Ishihara; N Yoshi
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-07

2.  Periodic appearance of theta rhythm in the frontal midline area during performance of a mental task.

Authors:  Y Mizuki; M Tanaka; H Isozaki; H Nishijima; K Inanaga
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1980-08

3.  [Study of vigilance after ingestion of zopiclone in comparison with nitrazepam and placebo (author's transl)].

Authors:  T Lemperiere; A Sarrazin; A Feline; M O Rucine; C Pilate; P Basset; J Simon
Journal:  Encephale       Date:  1980       Impact factor: 1.291

4.  Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.

Authors:  D D Breimer; R Jochemsen; H H von Albert
Journal:  Arzneimittelforschung       Date:  1980
  4 in total
  4 in total

1.  The role of brain oscillations as functional correlates of cognitive systems: a study of frontal inhibitory control in alcoholism.

Authors:  Chella Kamarajan; Bernice Porjesz; Kevin A Jones; Keewhan Choi; David B Chorlian; Ajayan Padmanabhapillai; Madhavi Rangaswamy; Arthur T Stimus; Henri Begleiter
Journal:  Int J Psychophysiol       Date:  2004-01       Impact factor: 2.997

Review 2.  Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 3.  Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.

Authors:  K L Goa; R C Heel
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

4.  Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis.

Authors:  Samar S Ayache; Ulrich Palm; Moussa A Chalah; Tarik Al-Ani; Arnaud Brignol; Mohamed Abdellaoui; Dalia Dimitri; Marc Sorel; Alain Créange; Jean-Pascal Lefaucheur
Journal:  Front Neurosci       Date:  2016-04-08       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.